cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339
The synthesis and characterization of cis-[OsIVCl4(κN2-1H-indazole)2] and its 1e-reduced analog are reported.
2016 ◽
Vol 20
(08n11)
◽
pp. 1256-1263
◽
2005 ◽
Vol 48
(25)
◽
pp. 8060-8069
◽
2012 ◽
Vol 22
(9)
◽
pp. 4146-4157
◽
Keyword(s):
2016 ◽
Vol 3
(10)
◽
pp. 3833-3837
◽
2006 ◽
Vol 9
(11)
◽
pp. 1075-1078
◽
1984 ◽
Vol 105
(1)
◽
pp. 259-271
◽
Keyword(s):